Co-Diagnostics CODX
NASDAQ CODX
$0.55 -0.02 (-4.30%)
At close: Oct 23, 2026 · 4:00 PM EDT

Co-Diagnostics (CODX) Other Accumulated Expenses (2016 - 2025)

Updated

Co-Diagnostics' Other Accumulated Expenses was $18,320 in Q4 2025, down 75.5% from $74,634 a year earlier.

Analysis

Co-Diagnostics (CODX) Other Accumulated Expenses (2016 - 2025) Analysis & Trends

From Q4 2016 onward, Co-Diagnostics has reported Other Accumulated Expenses for 8 quarters.

  • Other Accumulated Expenses shows a five-year compound annual growth rate of -55.7% (FY2020 to FY2025).
  • In earlier years, Other Accumulated Expenses was $74,634 in FY2024 (+188.4%), $25,883 in FY2023 (-92.5%), $346,368 in FY2022 (-61.3%) and $894,458 in FY2021 (-16.4%).
  • The Q4 2025 figure marks the lowest quarterly Other Accumulated Expenses in data going back to Q4 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.13 Bn 229.16 Bn 4.88 Bn
2 Abbott Laboratories 180.31 Bn 150.74 Bn 7.27 Bn
3 Danaher 162.34 Bn 146.15 Bn 3.61 Bn
4 Intuitive Surgical 158.13 Bn 138.42 Bn 2.08 Bn
5 Medtronic 122.37 Bn 87.63 Bn 6.34 Bn
6 Stryker 117.89 Bn 104.00 Bn 4.50 Bn
7 Boston Scientific 67.15 Bn 61.92 Bn 3.85 Bn
8 Becton Dickinson 54.68 Bn 51.83 Bn 2.32 Bn
9 Edwards Lifesciences 51.43 Bn 35.44 Bn 1.35 Bn
10 Co-Diagnostics 2.30 Mn -38.04 Mn 120,828.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 18,320.00
Dec 31, 2024 74,634.00
Dec 31, 2023 25,883.00
Dec 31, 2022 346,368.00
Dec 31, 2021 894,458.00
Dec 31, 2020 1.07 Mn
Jun 30, 2017 75,000.00
Dec 31, 2016 75,000.00
API Access

Co-Diagnostics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=CODX&period=max&api_key=YOUR_API_KEY